The intended audience for this educational initiative is nephrology clinicians, including nephrologists and nephrology nurses, who are clinicians responsible for managing patients with chronic kidney disease.
At the conclusion of this education, participants should be able to:
Summarize the etiology of anemia in chronic kidney disease
Describe the negative effects of anemia on health outcomes, quality of life, and functioning for patients with chronic kidney disease
Evaluate the advantages and limitations of current management strategies for anemia in chronic kidney disease
Assess the mechanism of action and efficacy and safety data for agents in late-stage development for the management of anemia of chronic kidney disease
USF Health adheres to the Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to influence content have disclosed to USF Health any financial relationship with an ineligible organization. USF Health has reviewed and mitigated all relevant financial relationships related to the content of the activity. The relevant financial relationships are listed below. All individuals not listed have no relevant financial relationships.
The faculty, authors, and content developers reported the following relevant financial relationships with ineligible companies:
Christine Chmielewski, MS, CRNP, ANP-BC,CNN-NP
Nephrology Nurse Practitioner
Jefferson Renal Associates
Thomas Jefferson University Hospital
Christine Chmielewski, MS, CRNP, ANP-BC,CNN-NP: Advisory Board or Panel: Vifor (Relationship Terminated); Consultant: Rockwell (Relationship Terminated); Speaker’s Bureau: AstraZeneca, Vifor
Matthew Weir, MD
Professor and Chief
Division of Nephrology
Department of Medicine
University of Maryland School of Medicine
Matthew Weir, MD: Advisory Board or Panel: Boehringer Ingelheim, Novo Nordisk, Bayer, Merck, AstraZeneca, GSK, Janssen, Vifor, and Akebia.
Jay Wish, MD
Professor of Clinical Medicine
Indiana University School of Medicine
Chief Medical Officer for Out-Patient Dialysis
Indiana University Health
Jay B. Wish, MD: Advisory Board or Panel: Fibrogen, Akebia, GlaxoSmithKline, Vifor Pharma, AstraZeneca, Otsuka, Amgen, Rockwell Medical, CSL Behring(Relationships Terminated) Speaker's Bureau: AstraZeneca, Akebia (Relationshipos Terminated)
There is no fee for this activity. To receive credit, participants must register, view the live CME/CNE/MOC activity in its entirety, and then complete the post-test, with a score of 70% or better, and evaluation. The estimated time for completion of this activity is one hour. To receive a certificate, participants must demonstrate mastery of the presented material via the post-test. Participants are allowed to take the post-test multiple times.
The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.
PHYSICIAN ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of USF Health and Rockpointe. USF Health is accredited by the ACCME to provide continuing medical education for physicians.
PHYSICIAN DESIGNATION CREDIT STATEMENT
USF Health designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NURSING ACCREDITATION STATEMENT
USF Health is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. A maximum of 1.0 contact hours may be earned by learners who successfully complete this continuing nursing education activity. USF Health, the accredited provider, acknowledges Rockpointe as the joint provider in the planning and execution of this CNE activity. This activity is awarded 1.0 ANCC pharmacotherapeutic contact hours.
ABIM MOC DESIGNATION STATEMENT
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points and patient safety MOC credit in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is USF Health’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
To receive CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through USF Health’s ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
Participants will earn MOC Points equivalent to the amount of CME credits claimed for the activity. USF Health will submit within 60 days the Participant’s MOC Points. No MOC certificates will be provided. Participants with questions regarding their Points, should contact USF Health at email@example.com
MIPS CREDIT DESIGNATION STATEMENT
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).
ABMS MOC APPROVAL STATEMENT
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Lowering the Burden of Anemia in CKD: Looking to the Future with HIF-PHIs has met the requirements as a Lifelong Learning CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:
ABMS Lifelong Learning CME Activity